Progressive Elevation of Store-Operated Calcium Entry-Associated Regulatory Factor (SARAF) and Calcium Pathway Dysregulation in Multiple Sclerosis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104520 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Safa Taha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Princess Al Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, Department of Molecular Medicine, College of Medicine and Health …. Hauptthemen laut MEDLINE: Intracellular Calcium-Sensing Proteins, Membrane Proteins, Multiple Sclerosis, Calcium Signaling. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple Sclerosis (MS) is a chronic autoimmune disorder characterized by demyelination and neuronal damage in the central nervous system. Dysregulation of calcium homeostasis, particularly through the Store-Operated Calcium Entry-Associated Regulatory Factor (SARAF), has been implicated in MS pathogenesis. This study investigated SARAF, STIM1, and Orai1 expression patterns and their relationship to calcium homeostasis in 45 Bahraini MS patients and 45 matched healthy controls using ELISA and real-time PCR analyses. MS patients showed significantly elevated serum SARAF levels in both early (192.26 ± 47.00 pg/mL) and late MS stages (341.47 ± 96.19 pg/mL) compared to controls (129.82 ± 30.82 pg/mL; p < 0.001. SARAF expressions were markedly increased in MS patients (3.829 ± 0.04422 vs. 1 ± 0; p < 0.0001), while STIM1 (0.4324 ± 0.01471) and ORAI1 (0.2963 ± 0.02156) expressions were significantly reduced compared to the controls (p < 0.0001). Intracellular calcium levels were notably elevated in both early and late MS stages. These findings suggest that the progressive elevation of SARAF, coupled with altered STIM1 and ORAI1 expression, may serve as potential biomarkers for MS progression and represent promising therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Al Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, Department of Molecular Medicine, College of Medicine and Health Sciences, Arabian Gulf University, Manama P.O. Box 26671, Bahrain.
- Aix-Marseille University, INSERM, TAGC, UMR1090, Equipe Labélisée Ligue Contre le Cancer, 13288 Marseille, France.
ORCID-Profile: Safa Taha, Muna Aljishi, Ameera Sultan, Moiz Bakhiet, Salvatore Spicuglia, Mohamed Belhocine
Zitieren
APA
Taha, S., Aljishi, M., Sultan, A., Al-Nashmi, M. E., Bakhiet, M., Spicuglia, S., & Belhocine, M. (2025). Progressive Elevation of Store-Operated Calcium Entry-Associated Regulatory Factor (SARAF) and Calcium Pathway Dysregulation in Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104520
Vancouver
Taha S, Aljishi M, Sultan A, Al-Nashmi ME, Bakhiet M, Spicuglia S, et al. Progressive Elevation of Store-Operated Calcium Entry-Associated Regulatory Factor (SARAF) and Calcium Pathway Dysregulation in Multiple Sclerosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104520
BibTeX
@article{Taha2025,
author = {Taha, Safa and Aljishi, Muna and Sultan, Ameera and Al-Nashmi, Moudi E and Bakhiet, Moiz and Spicuglia, Salvatore and Belhocine, Mohamed},
title = {Progressive Elevation of Store-Operated Calcium Entry-Associated Regulatory Factor (SARAF) and Calcium Pathway Dysregulation in Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104520}
}
EUVIMED